Thylacine Biotherapeutics Inc

Biotechnology company · Miami Beach, Florida, United States

Thylacine Biotherapeutics Inc is a biotechnology company headquartered in Miami Beach, Florida, United States. Its earliest recorded incorporation is in 2021. It has reported private securities offerings to the US SEC, most recently $476,000 sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Thylacine Biotherapeutics at a glance

Typebiotechnology company

HeadquartersMiami Beach, Florida, United States

Earliest incorporation on record2021

SEC CIK1962783

What does Thylacine Biotherapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $476,000 sold (2023).

Frequently asked questions about Thylacine Biotherapeutics

Where is Thylacine Biotherapeutics headquartered?

Thylacine Biotherapeutics Inc is headquartered in Miami Beach, Florida, United States.

What does Thylacine Biotherapeutics do?

Thylacine Biotherapeutics Inc is a biotechnology company.

When was Thylacine Biotherapeutics founded?

The earliest incorporation on record for Thylacine Biotherapeutics Inc is in 2021, according to public company registers.

Similar companies

SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
Genetic Networks, LLCMiami Beach, Florida, United States
Relation Therapeutics Inc.Miami Beach, Florida, United States
Immorta Bio, Inc.Miami Beach, Florida, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States
Vericel CorpBurlington, Massachusetts, United States
Adaptive Biotechnologies CorpSeattle, Washington, United States
Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences